Esperion to Host Virtual Key Opinion Leader Event on Wednesday, January 22, 2025, at 11:30 A.m. ET.

GlobeNewswireJan 9 21:00

BofA Securities Maintains Esperion Therapeutics(ESPR.US) With Sell Rating, Maintains Target Price $2.05

Futu NewsJan 6 19:34 · Ratings

Esperion to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireJan 2 21:00

Express News | Esperion Strengthens Balance Sheet With Closing of Significant Refinancing Transactions

BreakingsDec 18, 2024 20:00

Goldman Sachs Upgrades Esperion Therapeutics(ESPR.US) to Hold Rating, Raises Target Price to $4

Futu NewsDec 18, 2024 14:31 · Ratings

Cantor Fitzgerald Initiates Esperion Therapeutics(ESPR.US) With Buy Rating, Announces Target Price $8

Futu NewsDec 18, 2024 06:31 · Ratings